Department of Otorhinolaryngology, Kanazawa Medical University, Ishikawa, Japan.
Department of Nuclear Medicine, Graduate School of Medical Science, Kanazawa University, Ishikawa, Japan.
Sci Rep. 2017 Jun 15;7(1):3581. doi: 10.1038/s41598-017-03894-4.
Idiopathic olfactory disorder is resistant to treatment, and the recovery time is long. This study investigated the prognostic value of the migration of nasally administered thallium-201 to the olfactory bulb (thallium migration to the OB), a measure of olfactory nerve damage, in patients with idiopathic olfactory disorders. Twenty-four patients with idiopathic olfactory disorders were enrolled in the study (7 women and 17 men; aged 23-73 years). We retrospectively analyzed potential prognostic markers in subjects who underwent thallium-based olfactory imaging with the nasal administration of thallium-201 before conventional treatment with the Japanese herbal medicine tokishakuyakusan and compared those data with the prognosis. Log-rank tests were performed to assess the relationship between thallium migration to the OB (<4.6% [low] vs. ≥4.6% [high]; data dichotomized at the optimal cutoff value) and the duration until recovery of the odor recognition threshold determined by a standard olfactory function test (T&T olfactometry) after the treatment. Upon statistical analysis, we found that high thallium migration to the OB was significantly correlated with better prognosis in patients. Our results suggest that patients with intact olfactory nerve fibers could be selected using thallium-based imaging for the long-term follow-up of olfactory dysfunction.
特发性嗅觉障碍对治疗有抗性,恢复时间长。本研究探讨了经鼻给予铊-201 向嗅球迁移(铊向嗅球迁移),这是衡量嗅神经损伤的一种方法,在特发性嗅觉障碍患者中的预后价值。24 名特发性嗅觉障碍患者纳入本研究(7 名女性和 17 名男性;年龄 23-73 岁)。我们对接受基于铊的嗅觉成像的受试者进行了潜在预后标志物的回顾性分析,这些受试者在常规使用日本草药通经活络散治疗之前经鼻给予了铊-201,然后将这些数据与预后进行了比较。对数秩检验用于评估铊向嗅球迁移(<4.6%[低]与≥4.6%[高];数据在最佳截止值处二分类)与治疗后由标准嗅觉功能测试(T&T 嗅测法)确定的嗅觉识别阈值恢复的时间之间的关系。通过统计学分析,我们发现高铊向嗅球迁移与患者的更好预后显著相关。我们的结果表明,可使用基于铊的成像术选择嗅神经纤维完整的患者进行嗅觉障碍的长期随访。